812 filings
8-K
SNGX
Soligenix Inc
22 Apr 24
Soligenix Announces Pricing of $4.75 Million Public Offering
4:05pm
PRE 14A
SNGX
Soligenix Inc
Preliminary proxy
19 Apr 24
4:30pm
424B4
SNGX
Soligenix Inc
19 Apr 24
Prospectus supplement with pricing info
4:05pm
EFFECT
SNGX
Soligenix Inc
17 Apr 24
Notice of effectiveness
12:15am
8-K
SNGX
Soligenix Inc
3 Apr 24
Randomized Study with 18 Weeks Continuous Treatment Expected to Replicate and Extend Results from the First, Statistically Significant Phase 3 Study
4:05pm
8-K
wq3hzq4e ghauqc
22 Dec 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:05pm
EFFECT
ij3y iki91lkuryugop
18 Dec 23
Notice of effectiveness
12:15am
8-K
4jf7rfr9co01e
15 Dec 23
Submission of Matters to a Vote of Security Holders
4:03pm
CORRESP
jl4wc964bw
14 Dec 23
Correspondence with SEC
12:00am
CORRESP
cnhmd012i
6 Dec 23
Correspondence with SEC
12:00am
CORRESP
2r95qls0o5xt817 iyn1
30 Nov 23
Correspondence with SEC
12:00am
8-K
6o9brj881 zl61v
17 Nov 23
Soligenix, Inc. Announces Adjournment of Annual Meeting, Information for Reconvened Annual Meeting
4:05pm
8-K
c21x54otf mgehf432f
20 Oct 23
Soligenix, Inc. Announces Adjournment of Annual Meeting, Information for Reconvened Annual Meeting
4:05pm
DEFA14A
d9zj8ll9jf cfph3s232
17 Oct 23
Additional proxy soliciting materials
1:00pm